Monthly Archives: March 2025

Oliveda Reports Over $100M in U.S. Revenue in Year Two

Oliveda International, Inc. (OTC Pink: OLVI) announced that its Olive Tree People Inc. subsidiary has closed its second year in the United States with sales of $104,506,821 which corresponds to growth of almost 1700% in its second year.
This makes Olive Tree People Inc. not only the fastest growing waterless beauty company in the world, but also faster growing than many celebrity brands.
When asked about the breathtaking growth of Olive Tree People, Founder and CEO Thomas Lommel responded:

“I believe the time is ripe as more and more of the 168.6 million women in the U.S. are realizing the difference between conventional clean beauty and waterless beauty, and fewer and fewer of the 168.6m women in the U.S. are willing to spend money on up to 95% fillers, without achieving lasting results.
“More and more enlightened women want to know what 95% of products are made of instead of focusing exclusively on the 5%. People don’t just want sustainability from the marketing department, but sustainability that goes back to the roots of the company.
“I am convinced that we are experiencing a renaissance of the senses in which soulful and meaningful products make the difference and can therefore offer a 365-day satisfaction guarantee.

Read more...

LifeVantage Launches MB System™ in International Markets

LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is extending its groundbreaking MindBody GLP-1 System™ to international markets.
This expansion comes after a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024, in the U.S., largely driven by the system’s success, and clinical data on that formula reinforcing its effectiveness in supporting GLP-1 production.
The MB System™, as the product is known internationally, launched on March 15 for both LifeVantage Consultants and Customers in Japan. On the same date, it became available exclusively to Consultants in Australia, New Zealand, Europe, UK, Mexico, and Thailand; Customers in these regions gain access starting April 25.
The MB System™ is designed to naturally activate the body’s own GLP-1 production, providing a range of long-term health benefits that expand to weight management and beyond.*

“Consumers worldwide are seeking sustainable health solutions that go beyond short-term, unsustainable weight management. The MB System™ works harmoniously with the body, empowering individuals to naturally enhance their metabolic health in alignment with their lifestyle and wellness objectives,”*

shared Steve Fife, President and CEO of LifeVantage.

Meeting a Growing Global Demand
Interest in GLP-1 and metabolic health is rising worldwide. The global GLP-1 pharmaceutical market

Read more...

Primerica Reports Strong Fourth Quarter Results

Primerica, Inc. (NYSE: PRI) recently announced financial results for the quarter ended December 31, 2024. 
Total revenues of $788.1 million increased 12% compared to the fourth quarter of 2023. Net income from continuing operations of $167.7 million increased 9% while net earnings per diluted share from continuing operations of $4.98 increased 14% compared to the prior year period.
Adjusted operating revenues of $790.1 million increased 12% compared to the fourth quarter of 2023. Adjusted net operating income of $169.2 million increased 11%, while adjusted operating earnings per diluted share of $5.03 grew 17% compared to the prior year period.
Continued momentum during the fourth quarter led to a record number of life-licensed representatives at year-end, reflecting the ongoing interest and appeal of Primerica’s business opportunity. 
Financial results were notably strong, driven by steady premium revenue growth due to the cumulative impact of new policy sales in recent periods adding to the Company’s large block of in-force term life insurance policies. This growth, combined with higher ISP sales and rising client asset values which benefited from favorable equity market conditions, further strengthened overall performance.
Glenn Williams, CEO of Primerica, stated:

“Strong growth in 2024 has fueled another year of double-digit adjusted operating earnings growth for our stockholders

Read more...